Johanna Mejia-Fava – Trademark Portfolio
Entity Type: 01
Johanna Mejia-Fava holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DR. JO DOLPHINVET and DR. JO DOLPHIN, DVM. The owner is based in Key Largo, FL.
102411 Overseas Highway
Key Largo, FL 33037
Showing of trademarks Trademarks
Trademark Classifications
Johanna Mejia-Fava's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Johanna Mejia-Fava have?
Johanna Mejia-Fava has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned.
What trademark classes does Johanna Mejia-Fava file in?
Johanna Mejia-Fava files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Johanna Mejia-Fava's most well-known trademarks?
Johanna Mejia-Fava's registered trademark portfolio includes well-known marks such as DR. JO DOLPHINVET and DR. JO DOLPHIN, DVM. These are among 2 currently registered trademarks in the portfolio.
What is Johanna Mejia-Fava's trademark registration success rate?
Johanna Mejia-Fava has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.